InvestorsHub Logo

XenaLives

11/27/17 10:12 AM

#131873 RE: Mikesc #131872

Quite possible IMO...

McMagyar

11/27/17 10:17 AM

#131875 RE: Mikesc #131872

why would Anavex take MS off Clinical Development Board if this the case?
makes no sense..

talks may be in limbo..If you see MS back up on Anavex Clinical Chart Board..THEN..your scenario makes sense..

my guess is EVERY BP is out looking to BUY Sigma 1 Agonist development program..

Turner2017

11/27/17 10:28 AM

#131877 RE: Mikesc #131872

Maybe Missling is so cofident that 2-73 is the golden goose that he will go alone rather than taking a low offer. Time will tell.

attilathehunt

11/27/17 2:07 PM

#131962 RE: Mikesc #131872

If it truly tested positive in BIIB's lab, they would be all over it. They would pay up for the sure thing....Ah, there lies the befuddle.